• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒相关性口咽鳞癌放射敏感性增加的分子机制。

Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma.

机构信息

Department of Radiation Oncology, The First Hospital of Jilin University, Changchun 130021, China.

Department of Internal Medicine, Florida Hospital, Orlando, FL 32803, USA.

出版信息

Int J Biol Sci. 2020 Feb 4;16(6):1035-1043. doi: 10.7150/ijbs.40880. eCollection 2020.

DOI:10.7150/ijbs.40880
PMID:32140071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7053336/
Abstract

Oropharyngeal squamous cell carcinoma (OPSCC) is an important type of head and neck squamous cell carcinoma (HNSCC). The traditional risk factors for OPSCC include carcinogen intake, smoking, alcohol consumption, and lifestyle. In recent years, cases of human papillomavirus (HPV)-related OPSCC have gradually increased. At present, HPV-related OPSCC in developed Western countries comprise up to 90% of all OPSCC cases, while in other developing countries, the proportion of HPV-related OPSCC cases is also gradually increasing. Compared with HPV-negative OPSCC, HPV-positive OPSCC patients have better overall survival rates and local control rates and this improved prognosis may be related to the increased radiosensitivity of HPV-positive tumors. Due to this more favorable prognosis, many downgraded treatment schemes are gradually emerging, including simple radiotherapy instead of concurrent radiotherapy or reduced radiotherapy dose. However, there is insufficient theoretical basis for such schemes. Some studies have shown that delayed repair of DNA damage after radiation, G2/M arrest, increased hypoxia, and decreased proliferation capacity are the main reasons for the increased radiosensitivity of HPV-positive tumor cells. In this review, we discuss the four principles of tumor cell damage caused by radiation, including repair, reoxygenation, redistribution, and regeneration in order to reveal the mechanism whereby HPV increases the radiosensitivity of tumor cells. An attempt was made to provide sufficient information to facilitate more individualized treatment for HPV-positive OPSCC patients, under the premise of good tumor control.

摘要

口咽鳞状细胞癌(OPSCC)是头颈部鳞状细胞癌(HNSCC)的重要类型。OPSCC 的传统危险因素包括致癌物摄入、吸烟、饮酒和生活方式。近年来,人乳头瘤病毒(HPV)相关的 OPSCC 病例逐渐增多。目前,在发达的西方国家,HPV 相关的 OPSCC 占所有 OPSCC 病例的 90%以上,而在其他发展中国家,HPV 相关的 OPSCC 病例比例也在逐渐增加。与 HPV 阴性 OPSCC 相比,HPV 阳性 OPSCC 患者的总生存率和局部控制率更好,这种改善的预后可能与 HPV 阳性肿瘤的放射敏感性增加有关。由于这种更有利的预后,许多降级治疗方案逐渐出现,包括单纯放疗而不是同期放化疗或减少放疗剂量。然而,这些方案缺乏充分的理论依据。一些研究表明,放射后 DNA 损伤的延迟修复、G2/M 期阻滞、增加的缺氧和降低的增殖能力是 HPV 阳性肿瘤细胞放射敏感性增加的主要原因。在这篇综述中,我们讨论了放射引起肿瘤细胞损伤的四个原则,包括修复、再氧合、再分布和再生,以揭示 HPV 增加肿瘤细胞放射敏感性的机制。试图在良好的肿瘤控制的前提下,为 HPV 阳性 OPSCC 患者提供足够的信息,以实现更个体化的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8093/7053336/2d46b37ffc7b/ijbsv16p1035g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8093/7053336/2d46b37ffc7b/ijbsv16p1035g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8093/7053336/2d46b37ffc7b/ijbsv16p1035g001.jpg

相似文献

1
Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma.人乳头瘤病毒相关性口咽鳞癌放射敏感性增加的分子机制。
Int J Biol Sci. 2020 Feb 4;16(6):1035-1043. doi: 10.7150/ijbs.40880. eCollection 2020.
2
Sensitivity of human papillomavirus‑positive and ‑negative oropharyngeal cancer cell lines to ionizing irradiation.人乳头瘤病毒阳性和阴性口咽癌细胞系对电离辐射的敏感性。
Oncol Rep. 2020 Oct;44(4):1717-1726. doi: 10.3892/or.2020.7709. Epub 2020 Jul 31.
3
Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity.人乳头瘤病毒(HPV)阳性头颈部鳞状细胞癌中DNA损伤修复途径的调控异常会导致细胞对辐射敏感。
Oncotarget. 2017 May 2;8(18):29963-29975. doi: 10.18632/oncotarget.16265.
4
Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b.利用 miR-130b 预测 HPV 阴性口咽鳞状细胞癌的放射敏感性
Acta Otolaryngol. 2021 Jun;141(6):640-645. doi: 10.1080/00016489.2021.1897160. Epub 2021 Apr 1.
5
The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review.HPV 阳性口咽鳞状细胞癌(OPSCC)放射敏感性增加的分子机制:全面综述。
J Otolaryngol Head Neck Surg. 2018 Sep 21;47(1):59. doi: 10.1186/s40463-018-0302-y.
6
Role of Human Papilloma Virus and Lifestyle Factors in Overall Survival of Patients with Oropharyngeal Squamous Cell Carcinoma.人乳头瘤病毒和生活方式因素在口咽鳞状细胞癌患者总生存中的作用。
Medicina (Kaunas). 2022 Apr 18;58(4):557. doi: 10.3390/medicina58040557.
7
Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts.HPV 相关口咽鳞癌患者来源异种移植瘤的特征和放射敏感性。
Acta Oncol. 2019 Oct;58(10):1489-1494. doi: 10.1080/0284186X.2019.1660802. Epub 2019 Sep 11.
8
Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives.HPV 阳性头颈部癌症的放射敏感性增加:分子基础和治疗观点。
Cancer Treat Rev. 2015 Dec;41(10):844-52. doi: 10.1016/j.ctrv.2015.10.001. Epub 2015 Oct 13.
9
Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.人乳头瘤病毒(HPV)与口咽鳞状细胞癌
Presse Med. 2014 Dec;43(12 Pt 2):e429-34. doi: 10.1016/j.lpm.2014.08.010. Epub 2014 Nov 11.
10
Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.一种新型 HPV 相关口咽癌手术切除后复合病理风险分层的建立和评估。
JAMA Otolaryngol Head Neck Surg. 2019 Dec 1;145(12):1105-1114. doi: 10.1001/jamaoto.2019.0820.

引用本文的文献

1
Predictive and prognostic value of inflammatory factors (IL-6, IL-8, and TNF-α) in saliva for radiotherapy response in patients with HPV-associated oropharyngeal squamous cell carcinoma.炎症因子(IL-6、IL-8和TNF-α)在唾液中对人乳头瘤病毒相关口咽鳞状细胞癌患者放疗反应的预测和预后价值
Discov Oncol. 2025 Jul 18;16(1):1366. doi: 10.1007/s12672-025-02986-2.
2
HPV-Mediated Radiosensitivity in Oropharyngeal Squamous Cell Carcinoma: Molecular Mechanisms and Cellular Pathways.人乳头瘤病毒介导的口咽鳞状细胞癌放射敏感性:分子机制与细胞通路
Curr Oncol Rep. 2025 May;27(5):634-641. doi: 10.1007/s11912-025-01666-2. Epub 2025 Apr 11.
3

本文引用的文献

1
Validation of the 8 edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy.验证第 8 版 UICC/AJCC TNM 分期系统在接受当代放化疗治疗的 HPV 相关口咽癌患者中的应用。
BMC Cancer. 2019 Jul 9;19(1):674. doi: 10.1186/s12885-019-5894-8.
2
Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE.顺铂同步放化疗与西妥昔单抗生物放疗治疗p16阳性口咽癌的比较:一项纳入RTOG 1016和De-ESCALaTE试验的更新荟萃分析
Eur Arch Otorhinolaryngol. 2019 May;276(5):1275-1281. doi: 10.1007/s00405-019-05387-8. Epub 2019 Mar 18.
3
Performance analysis of Leica Biosystems p16 monoclonal antibody in oropharyngeal squamous cell carcinoma.
徕卡生物系统公司p16单克隆抗体在口咽鳞状细胞癌中的性能分析
Diagn Pathol. 2025 Jan 24;20(1):9. doi: 10.1186/s13000-025-01601-w.
4
The Complex Role of Mast Cells in Head and Neck Squamous Cell Carcinoma: A Systematic Review.肥大细胞在头颈部鳞状细胞癌中的复杂作用:系统评价。
Medicina (Kaunas). 2024 Jul 19;60(7):1173. doi: 10.3390/medicina60071173.
5
Radiobiology of Proton Therapy in Human Papillomavirus-Negative and Human Papillomavirus-Positive Head and Neck Cancer Cells.人乳头瘤病毒阴性和人乳头瘤病毒阳性头颈部癌细胞中质子治疗的放射生物学
Cancers (Basel). 2024 May 22;16(11):1959. doi: 10.3390/cancers16111959.
6
Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy.基于西妥昔单抗联合放疗替代顺铂联合放疗对 HPV 阳性口咽鳞癌降期作用的系统评价和荟萃分析
PeerJ. 2024 May 20;12:e17391. doi: 10.7717/peerj.17391. eCollection 2024.
7
FRZB: a potential prognostic marker for head and neck squamous cell carcinoma.FRZB:头颈部鳞状细胞癌的一个潜在预后标志物。
Braz J Med Biol Res. 2024 May 17;57:e13368. doi: 10.1590/1414-431X2024e13368. eCollection 2024.
8
Assessing the Knowledge of HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Vaccination, and Practice Scope among Saudi Dental Students in the Western Region.评估沙特西部地区牙科专业学生对人乳头瘤病毒相关口咽鳞状细胞癌、人乳头瘤病毒疫苗接种及执业范围的了解情况。
Healthcare (Basel). 2024 Apr 26;12(9):905. doi: 10.3390/healthcare12090905.
9
Butein inhibits oral squamous cell carcinoma growth via promoting MCL-1 ubiquitination.白杨素通过促进MCL-1泛素化抑制口腔鳞状细胞癌生长。
J Cancer. 2024 Apr 15;15(10):3173-3182. doi: 10.7150/jca.94546. eCollection 2024.
10
Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma.与口咽鳞状细胞癌中HPV整合引起的炎症反应相关的基因突变
Biomedicines. 2023 Dec 21;12(1):24. doi: 10.3390/biomedicines12010024.
De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
经口微创手术切除可切除的人乳头瘤病毒阳性口咽癌后,减量辅助(放)化疗与标准辅助放化疗的对比研究
Cochrane Database Syst Rev. 2018 Dec 14;12(12):CD012939. doi: 10.1002/14651858.CD012939.pub2.
4
Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus-Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center.降低 Memorial Sloan Kettering 癌症中心采用同步放化疗治疗的 HPV 相关口咽癌选择性治疗区域的放疗剂量处方
Pract Radiat Oncol. 2019 Mar;9(2):98-101. doi: 10.1016/j.prro.2018.10.015. Epub 2018 Nov 14.
5
Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications.70 岁及以上患者的人乳头瘤病毒相关性口咽癌:显著增加的患病率及临床意义。
Eur J Cancer. 2018 Nov;103:195-204. doi: 10.1016/j.ejca.2018.08.015. Epub 2018 Sep 27.
6
Dose-Modifying Factor of Radiation Therapy with Concurrent Cisplatin Treatment in HPV-Positive Squamous Cell Carcinoma: A Preclinical Study.HPV 阳性鳞状细胞癌同步顺铂治疗的放疗剂量调整因素:一项临床前研究。
Radiat Res. 2018 Jun;189(6):644-651. doi: 10.1667/RR14984.1. Epub 2018 Apr 13.
7
De-escalation treatment of human papillomavirus-positive oropharyngeal squamous cell carcinoma: an evidence-based review for the locally advanced disease.人乳头瘤病毒阳性口咽鳞状细胞癌的降阶梯治疗:局部晚期疾病的循证综述。
Curr Opin Oncol. 2018 May;30(3):146-151. doi: 10.1097/CCO.0000000000000441.
8
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.低剂量放疗治疗人乳头瘤病毒相关口咽鳞癌的单臂、2 期研究。
Lancet Oncol. 2017 Jun;18(6):803-811. doi: 10.1016/S1470-2045(17)30246-2. Epub 2017 Apr 20.
9
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.E1308:诱导化疗后降低剂量放疗联合西妥昔单抗每周治疗人乳头瘤病毒相关可切除口咽鳞状细胞癌患者的II期试验 - ECOG-ACRIN癌症研究组
J Clin Oncol. 2017 Feb 10;35(5):490-497. doi: 10.1200/JCO.2016.68.3300. Epub 2016 Dec 28.
10
Diagnostic accuracy of p16 immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.p16免疫组化在口咽鳞状细胞癌中的诊断准确性:一项系统评价和荟萃分析。
Int J Cancer. 2017 Mar 1;140(5):1186-1198. doi: 10.1002/ijc.30516. Epub 2016 Dec 2.